Price $24.48 |
Market Cap
1.37B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
133.7
|
P/B
4.3
|
P/S
1.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
53.8
|
Op. Cash Flow
146.4K
|
FCF
0.4
|
|
Op. Margin
3.20%
|
Net Margin
0.70%
|
ROE
3.40%
|
ROI
3.10%
|
|
ROA
0.50%
|
EPS Growth
-59.60%
|
Current Ratio
0.8
|
Debt/Equity
252.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cidara Therapeutics Inc (CDTX) | $1.28 | - | - | 129.6M | Strong Buy |
| DURECT Corp (DRRX) | $4.32 | - | - | 110.1M | Strong Buy |
| Dynatronics Corp (DYNT) | $1.49 | - | - | 7.4M | Strong Buy |
| PetIQ Inc (PETQ) | $11.23 | - | - | 315.7M | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $1.75 | - | - | 32.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
